Ameriprise’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-250,178
| Closed | -$1.25M | – | 3984 |
|
|
2024
Q1 | $1.25M | Sell |
250,178
-7
| -0% | -$35 | ﹤0.01% | 3079 |
|
|
2023
Q4 | $1.68M | Sell |
250,185
-36,231
| -13% | -$244K | ﹤0.01% | 2956 |
|
|
2023
Q3 | $2.62M | Hold |
286,416
| – | – | ﹤0.01% | 2690 |
|
|
2023
Q2 | $6.05M | Buy |
286,416
+18,832
| +7% | +$398K | ﹤0.01% | 2194 |
|
|
2023
Q1 | $7.2M | Buy |
267,584
+86,092
| +47% | +$2.32M | ﹤0.01% | 2039 |
|
|
2022
Q4 | $6.43M | Sell |
181,492
-87,651
| -33% | -$3.1M | ﹤0.01% | 2105 |
|
|
2022
Q3 | $60.8M | Buy |
269,143
+13,290
| +5% | +$3M | 0.02% | 623 |
|
|
2022
Q2 | $48.4M | Buy |
255,853
+6,018
| +2% | +$1.14M | 0.02% | 731 |
|
|
2022
Q1 | $62.2M | Buy |
249,835
+15,011
| +6% | +$3.74M | 0.02% | 709 |
|
|
2021
Q4 | $36.6M | Buy |
234,824
+37,835
| +19% | +$5.89M | 0.01% | 986 |
|
|
2021
Q3 | $39.5M | Buy |
196,989
+13,155
| +7% | +$2.64M | 0.01% | 878 |
|
|
2021
Q2 | $47M | Buy |
183,834
+35,493
| +24% | +$9.07M | 0.01% | 824 |
|
|
2021
Q1 | $39.4M | Buy |
148,341
+17,613
| +13% | +$4.68M | 0.01% | 886 |
|
|
2020
Q4 | $48.2M | Buy |
130,728
+84,326
| +182% | +$31.1M | 0.02% | 752 |
|
|
2020
Q3 | $11.3M | Buy |
+46,402
| New | +$11.3M | ﹤0.01% | 1470 |
|